Once BCG unresponsive, always BCG unresponsive: An open letter to the FDA to enhance recruitment into clinical trials in bladder cancer

Kamat, A. M., Lerner, S., Black, P., Bellmunt, J., Dinney, C., Hahn, N. M., … Quale, D. Z. (2017). Once BCG unresponsive, always BCG unresponsive: An open letter to the FDA to enhance recruitment into clinical trials in bladder cancer. Bladder Cancer. IOS Press. https://doi.org/10.3233/BLC-170118